Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04774952
Title Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Revolution Medicines, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST